SCHEMBL5247111

SCHEMBL5247111

C=CCCCOc1cc(C(=O)NCC(F)(F)F)ccc1-n1cc(C(=O)NCCc2cccs2)nn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 9/20 0.41
▸ RAB9A P51151 8/20 0.41
▸ SMN1; SMN2 Q16637 6/20 0.41
▸ ALDH1A1 P00352 4/20 0.41
▸ MAPT P10636 1/20 0.41
▸ HPGD P15428 3/20 0.41
▸ CYP1A2 P05177 2/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.40
▸ BRD4 O60885 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ MIF P14174 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ TAAR1 Q96RJ0 1/20 0.37
▸ DRD2 P14416 2/20 0.36
▸ DRD3 P35462 2/20 0.36
▸ NAMPT P43490 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5249193 0.91 NPC1 (0.42) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT
SCHEMBL5246566 0.90 NPC1 (0.47) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT
SCHEMBL5244507 0.89 BRD4 (0.40) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT
SCHEMBL3111906 0.89 SMPD1 (0.38) BRD4DRD2DRD3
SCHEMBL5247629 0.88 DGAT1 (0.34) —
SCHEMBL5249178 0.88 SMPD1 (0.34) ALDH1A1HPGDKDM4EBRD4DRD2
SCHEMBL5244268 0.87 PDK2 (0.35) POLBDRD2DRD3
SCHEMBL3116642 0.87 TP53 (0.40) SMN1; SMN2HPGDCYP1A2CYP2C9CYP2C19
SCHEMBL5246240 0.87 NPC1 (0.39) NPC1RAB9ASMN1; SMN2ALDH1A1BRD4
SCHEMBL5247112 0.87 MLYCD (0.40) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1867331-A1 TRIAZOLE DERIVATIVE AND THE USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2007-12-19 — — EP disclosed
Send feedback